Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date2/26/2019 (Confirmed)
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) released its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.43) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.51) by $0.08. The company earned $10.94 million during the quarter, compared to analysts' expectations of $9.30 million. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
How can I listen to Inspire Medical Systems' earnings call?
Inspire Medical Systems will be holding an earnings conference call on Tuesday, February 26th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8882208451.
What price target have analysts set for INSP?
8 brokers have issued 12-month target prices for Inspire Medical Systems' stock. Their predictions range from $25.00 to $64.00. On average, they expect Inspire Medical Systems' stock price to reach $41.6250 in the next year. This suggests that the stock has a possible downside of 27.1%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
News headlines about INSP stock have trended positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include Helius Medical Technologies (HSM), Avita Medical (AVH), Hamilton Thorne (HTL), Titan Medical (TMD), REVA Medical (RVA), Protech Home Medical (PHM), Electromed (ELMD), Osprey Medical (OSP), Universal Biosensors (UBI), Resonance Health (RHT), EMvision Medical Devices (EMV), Anteo Diagnostics (ADO), GI Dynamics (GID), Myomo (MYO) and Myomo (MYO).
What other stocks do shareholders of Inspire Medical Systems own?
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Orbimed Advisors LLC (8.55%), BlackRock Inc. (3.76%), Lord Abbett & CO. LLC (3.65%), Millennium Management LLC (1.28%), Mairs & Power INC (0.73%) and Northern Trust Corp (0.73%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which institutional investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC and Jennison Associates LLC. Company insiders that have sold Inspire Medical Systems company stock in the last year include Jerry C Griffin, Joyce Erony, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
Which institutional investors are buying Inspire Medical Systems stock?
INSP stock was purchased by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, BlackRock Inc., Millennium Management LLC, Kornitzer Capital Management Inc. KS, Castleark Management LLC, Monashee Investment Management LLC, Dimensional Fund Advisors LP and Geode Capital Management LLC. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $57.10.
How big of a company is Inspire Medical Systems?
Inspire Medical Systems has a market capitalization of $1.22 billion.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
